InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the complete record of transactions filed by Leaman John Harold. Director active across 1 company, notably IMPEL PHARMACEUTICALS INC. Cumulatively, 1 filings have been recorded. Activity tracked since 31 December 2022. The latest transaction was filed on 31 December 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration